Serum nitric oxide metabolites and hard clinical endpoints: a population-based prospective study

References

• World Health Organization. Cardiovascular diseases (CVDs) fact sheet 2017 [cited 2017 Dec 31]. Available from: www.who.int/mediacentre/factsheets/fs317/en
   Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
   PubMed Web of Science ®Google Scholar
• Ge Y, Wang TJ. Identifying novel biomarkers for cardiovascular disease risk prediction. J Intern Med. 2012;272:430–439.
   PubMed Web of Science ®Google Scholar
• Hozawa A, Folsom AR, Sharrett AR, et al. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects–Atherosclerosis Risk in Communities Study. Arch Intern Med. 2007;167:573–579.
   PubMedGoogle Scholar
• Ajani UA, Ford ES. Has the risk for coronary heart disease changed among U.S. adults? J Am Coll Cardiol. 2006;48:1177–1182.
   PubMed Web of Science ®Google Scholar
• Ghasemi A, Zahediasl S. Is nitric oxide a hormone? Iranian Biomed J. 2011;15:59–65.
   PubMedGoogle Scholar
• Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7:156–167.
   PubMed Web of Science ®Google Scholar
• Knott AB, Bossy-Wetzel E. Impact of nitric oxide on metabolism in health and age-related disease. Diabetes Obes Metab. 2010;12:126–133.
   PubMed Web of Science ®Google Scholar
• Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol. 2008;294:F1–9.
   PubMed Web of Science ®Google Scholar
• Masha A, Dinatale S, Allasia S, et al. Role of the decreased nitric oxide bioavailability in the vascular complications of diabetes mellitus. CPB. 2011;12:1354–1363.
   Google Scholar
• Stoclet JC, Muller B, Andriantsitohaina R, et al. Overproduction of nitric oxide in pathophysiology of blood vessels. Biochem Biokhimiia. 1998;63:826–832.
   PubMed Web of Science ®Google Scholar
• Perreault M, Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med. 2001;7:1138–1143.
   PubMed Web of Science ®Google Scholar
• Hewala TI, Abd El-Moneim NA, Ebied SA, et al. Diagnostic and prognostic value of serum nitric oxide, tumor necrosis factor-alpha, basic fibroblast growth factor and copper as angiogenic markers in premenopausal breast cancer patients: a case-control study. Brit J Biomed Sci. 2010;67:167–176.
   PubMed Web of Science ®Google Scholar
• Muto S, Takagi H, Owada Y, et al. Serum nitric oxide as a predictive biomarker for bevacizumab in non-small cell lung cancer patients. Anticancer Res. 2017;37:3169–3174.
   PubMed Web of Science ®Google Scholar
• Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. European Heart J. 2012;33:829–837d.
   PubMed Web of Science ®Google Scholar
• Feng Q, Lu X, Jones DL, et al. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation. 2001;104:700–704.
   PubMed Web of Science ®Google Scholar
• Gumanova NG, Deev AD, Zhang W, et al. Serum nitrite and nitrate levels, NOx, can predict cardiovascular mortality in the elderly in a 3-year follow-up study. BioFactors (Oxford, England). 2017;43:82–89.
   PubMed Web of Science ®Google Scholar
• Beberashvili I, Sinuani I, Azar A, et al. Increased basal nitric oxide amplifies the association of inflammation with all-cause and cardiovascular mortality in prevalent hemodialysis patients. Int Urol Nephrol. 2013;45:1703–1713.
   PubMed Web of Science ®Google Scholar
• Ghasemi A, Zahediasl S, Azizi F. Reference values for serum nitric oxide metabolites in an adult population. Clin Biochem. 2010;43:89–94.
   PubMed Web of Science ®Google Scholar
• Bahadoran Z, Mirmiran P, Ghasemi A, et al. Serum nitric oxide metabolites are associated with the risk of hypertriglyceridemic-waist phenotype in women: Tehran Lipid and Glucose Study. Nitric Oxide. 2015;50:52–57.
   PubMed Web of Science ®Google Scholar
• Bahadoran Z, Mirmiran P, Tahmasebi Nejad Z, et al. Serum nitric oxide is associated with the risk of chronic kidney disease in women: Tehran lipid and glucose study. Scand J Clin Lab Invest. 2016;76:304–308.
   PubMed Web of Science ®Google Scholar
• Hadaegh F, Asgari S, Bozorgmanesh M, et al. Added value of total serum nitrate/nitrite for prediction of cardiovascular disease in middle east caucasian residents in Tehran. Nitric Oxide. 2016;54:60–66.
   PubMed Web of Science ®Google Scholar
• Azizi F, Rahmani M, Emami H, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 2002;47:408–426.
   PubMedGoogle Scholar
• Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.
   PubMed Web of Science ®Google Scholar
• Momenan AA, Delshad M, Sarbazi N, et al. Reliability and validity of the Modifiable Activity Questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med. 2012;15:279–282.
   PubMed Web of Science ®Google Scholar
• Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5:62–71.
   PubMed Web of Science ®Google Scholar
• Ghasemi A, Hedayati M, Biabani H. Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay. JMSR. 2007;2:29–32.
   Google Scholar
• Ghasemi A, Zahediasl S, Azizi F. Elevated nitric oxide metabolites are associated with obesity in women. Arch Iran Med. 2013;16:521–525.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2014;37:S14–S80.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Sardarinia M, Akbarpour S, Lotfaliany M, et al. Risk factors for incidence of cardiovascular diseases and all-cause mortality in a Middle Eastern Population over a decade follow-up: Tehran Lipid and glucose study. PLoS One. 2016;11:e0167623.
   PubMed Web of Science ®Google Scholar
• Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670–675.
   PubMed Web of Science ®Google Scholar
• Ghasemi A, Zahediasl S, Azimzadeh I, et al. Increased serum nitric oxide metabolites in dysglycaemia. Ann Hum Biol. 2011;38:577–582.
   PubMed Web of Science ®Google Scholar
• Ghasemi A, Zahediasl S, Azizi F. High serum nitric oxide metabolites and incident metabolic syndrome. Scand J Clin Lab Invest. 2012;72:523–530.
   PubMed Web of Science ®Google Scholar
• Ghasemi A, Zahediasl S, Syedmoradi L, et al. Association between serum nitric oxide metabolites and hypertension in a general population. Int Angiol. 2011;30:380–387.
   PubMed Web of Science ®Google Scholar
• Shah AM. Inducible nitric oxide synthase and cardiovascular disease. Cardiovasc Res. 2000;45:148–155.
   PubMed Web of Science ®Google Scholar
• Viaro F, Nobre F, Evora PR. Expression of nitric oxide synthases in the pathophysiology of cardiovascular diseases. Arquivos Brasileiros de Cardiologia. 2000;74:380–393.
   PubMedGoogle Scholar
• Zahedi Asl S, Ghasemi A, Azizi F. Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin Biochem. 2008;41:1342–1347.
   PubMed Web of Science ®Google Scholar
• Osawa M, Hayashi T, Nomura H, et al. Nitric oxide (NO) is a new clinical biomarker of survival in the elderly patients and its efficacy might be nearly equal to albumin. Nitric Oxide. 2007;16:157–163.
   PubMed Web of Science ®Google Scholar
• Maas R, Xanthakis V, Goen T, et al. Plasma nitrate and incidence of cardiovascular disease and all-cause mortality in the community: The Framingham Offspring Study. J Am Heart Assoc. 2017;6:e006224.
   Web of Science ®Google Scholar
• Lundberg JO, Govoni M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med. 2004;37:395–400.
   Web of Science ®Google Scholar
• Gilchrist M, Shore A. Inorganic nitrate: marker or mediator of mortality? J Am Heart Assoc. 2017;6:e007782.
   Web of Science ®Google Scholar